Pharmaceutical Industry Information Portal

HomeNews

News

Open Orphan awarded £5mln RSV challenge study contract

Open Orphan plc., announces that hVIVO, a subsidiary of Open Orphan, has signed a £5m respiratory syncytial virus (RSV) human challenge study contract with...

Insilico Medicine and EQRx will collaborate to jointly advance AI-driven drug discovery

Insilico Medicine ("Insilico"), a clinical stage end-to-end artificial intelligence (AI)-driven drug discovery company, on Tuesday announced it has entered into a strategic collaboration with...

Sandoz recalls of 13 lots of orphenadrine citrate extended release tablets

Sandoz Inc. (“Sandoz”) is initiating a voluntary recall of 13 lots of oral Orphenadrine Citrate 100 mg Extended Release (ER) Tablets to the consumer...

LifeMine and GSK sign cooperation agreement to search for small molecules

LifeMine Therapeutics Inc., a biopharmaceutical company reinventing drug discovery by mining genetically-encoded small molecules (GEMs) from the biosphere, today announced a strategic R&D collaboration...

Moderna will produce its mRNA vaccines in Melbourne, Australia

Moderna, Inc., on Wednesday announced the finalization of a strategic partnership with the Australian Federal Government to establish a state-of-the-art, domestic mRNA vaccine manufacturing...

Novartis targeted radiation therapy gets FDA nod for PSMA

Novartis announced today that the US Food and Drug Administration (FDA) approved Pluvicto™(lutetium Lu 177 vipivotide tetraxetan) for the treatment of adult patients with...
spot_img

Expert Articles

spot_img